Valuation: Attana AB

Market Cap 7.74M 818K 700K 655K 600K 1.13M 78.29M 1.14M 3.02M 39.29M 3.07M 3M 131M P/E 2024
-0.31x
P/E 2025 -1.11x
Enterprise Value 7.6M 803K 687K 643K 588K 1.11M 76.82M 1.12M 2.96M 38.55M 3.01M 2.95M 129M EV / Sales 2024
0.57x
EV / Sales 2025 5x
Free-Float
1.63%
Yield 2024 *
-
Yield 2025 -
3 months-50.00%
6 months-66.67%
Current year-66.67%
1 week 0
Extreme 0.002
0
1 month 0
Extreme 0.002
0
Current year 0
Extreme 0.002
0.01
1 year 0
Extreme 0.002
0.02
3 years 0
Extreme 0.002
0.27
5 years 0
Extreme 0.002
1.24
10 years 0
Extreme 0.002
2.4
Manager TitleAgeSince
Chief Executive Officer - 31/03/2025
Chief Executive Officer 56 31/08/2002
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member 56 05/08/2012
Chairman 63 30/09/2015
Director/Board Member 62 31/12/2017
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-88.00%-98.87% 817K
+0.70%+3.10%-39.61%-41.80% 627M
-7.78%-19.14%+81.42% - 368M
-12.62%-2.23%-30.89%-3.30% 156M
-5.21%-18.02%-26.02%+19.74% 74.83M
Average -4.98%+4.31%-20.62%-31.06% 245.31M
Weighted average by Cap. -3.90%-4.46%-1.36%-29.50%

Financials

2024 2025
Net sales 6.61M 699K 598K 560K 512K 962K 66.88M 975K 2.58M 33.56M 2.62M 2.57M 112M 4.01M 424K 363K 339K 310K 583K 40.53M 591K 1.56M 20.34M 1.59M 1.56M 67.84M
Net income -12.78M -1.35M -1.16M -1.08M -990K -1.86M -129M -1.88M -4.98M -64.84M -5.07M -4.96M -216M -10.5M -1.11M -950K -889K -813K -1.53M -106M -1.55M -4.09M -53.3M -4.17M -4.08M -178M
Net Debt 1.17M 124K 106K 99.08K 90.7K 170K 11.84M 173K 456K 5.94M 465K 454K 19.82M -145K -15.37K -13.16K -12.31K -11.26K -21.16K -1.47M -21.44K -56.69K -738K -57.71K -56.45K -2.46M
Logo Attana AB
Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attana’s biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Employees
6
Date Price Change Volume
21/08/26 SEK 0.003000 0.00% 13,573,704
20/08/26 SEK 0.003000 0.00% 5,989,387
19/08/26 SEK 0.003000 0.00% 1,919,237
18/08/26 SEK 0.003000 +50.00% 7,407,318
17/08/26 SEK 0.002000 -33.33% 18,304,331
  1. Stock Market
  2. Stocks
  3. ATANA Stock